Skip to Main Content

Author Details

Bali Pulendran
Institute for Immunity, Stanford University School of Medicine, Stanford University
1990
234
87
PMIDPaper TitleJournal TitlePublished Year
38036767BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.Nat Immunol2024
38036767BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.Nat Immunol2024
36732946Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2.Cell Rep2023
37918220Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208].EBioMedicine2023
37577608Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation.bioRxiv2023
37986828Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants.bioRxiv2023
37798288Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.Nat Commun2023
37776858Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.Cell2023
37553348Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.Nat Commun2023
37155869Circular RNA vaccine induces potent T cell responses.Proc Natl Acad Sci U S A2023
36717665A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2.Nat Mater2023
36778389Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life.medRxiv2023
37020354Progress in vaccine development for infectious diseases-a Keystone Symposia report.Ann N Y Acad Sci2023
36711543Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.bioRxiv2023
36577930SREBP signaling is essential for effective B cell responses.Nat Immunol2023
36951954Durability of immune responses to mRNA booster vaccination against COVID-19.J Clin Invest2023
36572838Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.Nat Immunol2023
37069151A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.Nat Commun2023
37443176Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.NPJ Vaccines2023
36996809Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection.Immunity2023
36732946Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2.Cell Rep2023
37225997Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans.Nature2023
37163615Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.Sci Transl Med2023
37918220Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208].EBioMedicine2023
37798288Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.Nat Commun2023
37553348Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques.Nat Commun2023
37986828Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants.bioRxiv2023
37577608Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Improve Vaccine Immunomodulation.bioRxiv2023
37776858Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.Cell2023
36951954Durability of immune responses to mRNA booster vaccination against COVID-19.J Clin Invest2023
37155869Circular RNA vaccine induces potent T cell responses.Proc Natl Acad Sci U S A2023
37020354Progress in vaccine development for infectious diseases-a Keystone Symposia report.Ann N Y Acad Sci2023
37443176Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.NPJ Vaccines2023
37069151A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates.Nat Commun2023
37225997Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans.Nature2023
37163615Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine.Sci Transl Med2023
36996809Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infection.Immunity2023
36717665A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2.Nat Mater2023
36778389Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life.medRxiv2023
36577930SREBP signaling is essential for effective B cell responses.Nat Immunol2023
36711543Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.bioRxiv2023
36572838Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.Nat Immunol2023
34002068Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms.Nat Rev Immunol2022
35588691Epigenetic adjuvants: durable reprogramming of the innate immune system with adjuvants.Curr Opin Immunol2022
36239699Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.Elife2022
36266291The Immune Signatures data resource, a compendium of systems vaccinology datasets.Sci Data2022
35988541Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.Cell Rep2022
35606518Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.NPJ Vaccines2022
36316476Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.Nat Immunol2022
36316475Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.Nat Immunol2022
  • 1 - 50 of 468

Recommended Authors

Institute for Immunology, University of Pennsylvania Perelman School of Medicine
Career Start Year 2018
Number of shared co-authors 2
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 3
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 1
University of Alabama at Birmingham Birmingham
Career Start Year 2011
Number of shared co-authors 2
Sorbonne University INSERM
Career Start Year 2010
Number of shared co-authors 5
University of Maryland
Career Start Year 2010
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 5
Institute of Veterinary Disease Control
Career Start Year 2006
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2005
Number of shared co-authors 4
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 3
University of Maryland School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Drexel University College of Medicine
Career Start Year 2004
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2003
Number of shared co-authors 1
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 13
Yale School of Medicine, Yale University
Career Start Year 2002
Number of shared co-authors 3
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 9
University of Rochester Medical Center
Career Start Year 1999
Number of shared co-authors 3
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1998
Number of shared co-authors 0
National Institute of Allergy and Infectious Diseases
Career Start Year 1994
Number of shared co-authors 2
Telethon Kids Institute
Career Start Year 1991
Number of shared co-authors 7
Yale School of Medicine, Yale University
Career Start Year 1987
Number of shared co-authors 3
Mayo Clinic Vaccine Research Group
Career Start Year 1985
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 5

Collaborators

Co-authored papers 31
Co-authored papers 30
Co-authored papers 24
Co-authored papers 23
Co-authored papers 18
Co-authored papers 17
Co-authored papers 16
Co-authored papers 16
Co-authored papers 13
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Co-authored papers 11
Co-authored papers 11
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
University of California San Francisco
Co-authored papers 9
Co-authored papers 9
University of California
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8